One of the most compelling designs in human research begins with a paradox: two people with essentially the same inherited DNA, but only one later develops coronary artery disease.
A Danish study published online in December 2025 examined exactly this situation in 44 discordant twin pairs, combining genome-wide DNA methylation with gene-expression data. The result is fascinating — and a lesson in why exploratory science must remain exploratory.
Quick answer
Did the study discover an epigenetic cause of coronary artery disease?
No. It found group-level methylation and gene-expression patterns, particularly involving immune and inflammatory pathways, in twins who developed CAD compared with their co-twins. The study was small and explicitly calls for additional research; these patterns are not validated diagnostic or causal biomarkers.
Key takeaways
- The study included 44 Danish twin pairs discordant for incident coronary artery disease.
- Researchers combined genome-wide DNA methylation and gene-expression data.
- CAD co-twins showed patterns consistent with up-regulated expression, with immune-inflammatory pathways prominent in enrichment analyses.
- Epigenetic association does not reveal whether the change was a cause, consequence or correlate of disease risk.
- The strongest TwinPare message is the study design itself: genetically matched people can still develop biologically different trajectories.
What “epigenetics” means here
DNA methylation is a chemical modification of DNA that can be associated with how genes are regulated without changing the DNA sequence itself. Gene-expression analysis measures which genes are producing more or less RNA in the sampled tissue.
Neither measurement is a permanent label of fate. Both can vary by cell type, age, exposures, disease processes and technical factors.
Why discordant twins are so useful
When twins differ in disease outcome, the co-twin design can reduce confounding from family background. If the pair is monozygotic, inherited sequence differences are reduced even further.
Researchers can then ask whether molecular differences are enriched in the twin who later develops disease. The design narrows the search, but it does not automatically prove that the molecular difference caused the disease.
What the researchers found
The study reported a broad pattern in which CAD co-twins showed methylation configurations associated with up-regulated gene expression, including promoter demethylation and gene-body methylation patterns.
In pathway analyses, the largest group of up-regulated biological pathways related to immune and inflammatory processes, while several down-regulated pathways involved muscle-system biology. These are pathway-level exploratory signals, not a clinical test.
Why this result needs restraint
Forty-four pairs is valuable for a deeply characterized twin design, but small for genome-wide multi-omics work where thousands of features are tested.
The authors themselves emphasize the need for additional studies. A plausible inflammatory pattern can generate hypotheses for future research, but it cannot tell a reader why they personally developed coronary disease or predict who will develop it.
TwinPare perspective: same genome does not mean same biology forever
Identical twins begin with near-identical inherited DNA, not identical lives. Smoking, infections, medication, diet, activity, stress, metabolic health and random biological events can diverge over decades.
Epigenetic twin research is exciting because it asks how those differences become biologically visible. Its value lies in generating better questions — not in pretending an early molecular signal is already a diagnosis.
Source notes
The source has been verified and editorially reviewed for this article. The limitations below show which level of conclusion the sources support.
- [skovgaard-2025-cad] Twin pairs discordant for incident coronary artery disease reveal epigenetic and transcriptomic differences by gene region Asmus Cosmos Skovgaard et al.. Molecular Genetics and Genomics, 2025. Evidence type: Multi-omics study of 44 Danish twin pairs discordant for incident coronary artery disease Limitation: Immune/inflammation-related pathway patterns were exploratory. No individual CpG/probe should be treated as a clinically validated CAD biomarker from this small discordant-pair study. PubMed PMC DOI
Editorial source review
This section shows how the article's key factual claims are linked to the source.
Phrasings that require caution
- Describe the molecular findings as exploratory and hypothesis-generating.
- Do not imply DNA methylation proves a lifestyle exposure caused CAD.
- Do not present these patterns as a validated screening or diagnostic test.
| ID | Claim | Source support | Caution |
|---|